By Hank Schultz, 20-Oct-2015
Investment opportunities in the CBD space continue to abound despite the regulatory uncertainties, the director of a Boulder-based fund says.
“It has enormous applications. It is an antioxidant, it protects brain cells, there are some studies out from the NIH that shows it destroys cancer cells,” Patrick Rea said, a former editor of Nutrition Business Journal.
“They are just seriously understudied because the DEA controls the licenses that are assigned or given to clinicians, academics and researchers. Let’s not forget that cannabis is still a Schedule One drug,” he said.
Read the full article at:
Visit our blog at CBD PUR US for more news, information, and interesting facts about Cannabidiol (CBD).